Himension Capital Expands Global Equity Footprint

Himension Capital Singapore PTE. LTD. expanded its portfolio across several U.S. and global equities in the first quarter, including a new position in BHP Group via 23,436 shares valued at about $1.7 million. The fund also disclosed a new stake in the ARK Genomic Revolution ETF with 85,164 shares worth approximately $2.25 million. In USA Rare Earth, the firm acquired 136,512 shares for roughly $2.07 million, alongside broader activity from other large investors. The position in Lam Research grew by 5.1% to 50,858 shares, valued around $10.9 million, marking it as a substantial holding in its mix. Tempus AI also saw a notable increase, with 48,114 shares purchased for about $2.18 million, up 42.6% from the prior period. Overall, the activity signals a diversified expansion across energy, genomics, semiconductors, and AI-focused equities in the first quarter.